Literature DB >> 20097185

Direct detection of the hydrolysis of nerve agent model compounds using a fluorescent probe.

Xueying Zheng1, Karl Okolotowicz, Beilin Wang, Mary Macdonald, John R Cashman, Jun Zhang.   

Abstract

Nerve agents are highly toxic organophosphorus compounds (OPs) that are used as chemical warfare agents. Developing a catalytic bioscavenger to efficiently detoxify nerve agents in the bloodstream of affected individuals has been recognized as an attractive approach to prevent nerve agent toxicity. However, the search for nerve agent catalysts has been hindered by the lack of efficient direct assays for nerve agent hydrolysis. In addition, authentic nerve agents are restricted and access to use for experiments by the general research community is prohibited. Herein we report development of a method that combines use of novel nerve agent model compounds possessing a thiocholine leaving group that reacts with the fluorescent thio-detection probe, BES-Thio, to afford detection of sub-micromolar amounts of nerve agent model compounds hydrolysis products. The detection sensitivity of BES-Thio assay was approximately 10 times better than the Ellman assay. This developed method is useful as a direct, sensitive screening method for evaluating OP hydrolysis efficiency from catalytic cholinesterases. When the assay was assembled in the presence of oxime, OP-inhibited cholinesterases that were able to be reactivated by specific oxime showed oxime-assisted enzyme-mediated OP hydrolysis. Therefore, this method is also useful to screen oxime analogs to identify novel agents that can reactivate OP-inhibited cholinesterases or to screen various enzymes to identify pseudo-catalytic bioscavengers that can be readily reactivated by clinically approved oximes. Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20097185      PMCID: PMC2890299          DOI: 10.1016/j.cbi.2010.01.027

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  13 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

2.  2,4-Dinitrobenzenesulfonyl fluoresceins as fluorescent alternatives to Ellman's reagent in thiol-quantification enzyme assays.

Authors:  Hatsuo Maeda; Hiromi Matsuno; Mai Ushida; Kohei Katayama; Kanako Saeki; Norio Itoh
Journal:  Angew Chem Int Ed Engl       Date:  2005-05-06       Impact factor: 15.336

3.  Chiral reactions of acetylcholinesterase probed with enantiomeric methylphosphonothioates. Noncovalent determinants of enzyme chirality.

Authors:  H A Berman; K Leonard
Journal:  J Biol Chem       Date:  1989-03-05       Impact factor: 5.157

Review 4.  Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review.

Authors:  David E Lenz; David Yeung; J Richard Smith; Richard E Sweeney; Lucille A Lumley; Douglas M Cerasoli
Journal:  Toxicology       Date:  2006-12-01       Impact factor: 4.221

5.  A single amino acid substitution, Gly117His, confers phosphotriesterase (organophosphorus acid anhydride hydrolase) activity on human butyrylcholinesterase.

Authors:  O Lockridge; R M Blong; P Masson; M T Froment; C B Millard; C A Broomfield
Journal:  Biochemistry       Date:  1997-01-28       Impact factor: 3.162

6.  Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.

Authors:  Gabi Amitai; Rellie Adani; Guy Yacov; Shelly Yishay; Shai Teitlboim; Liat Tveria; Osnat Limanovich; Moshe Kushnir; Haim Meshulam
Journal:  Toxicology       Date:  2006-10-13       Impact factor: 4.221

7.  Chemical synthesis of two series of nerve agent model compounds and their stereoselective interaction with human acetylcholinesterase and human butyrylcholinesterase.

Authors:  Nora H Barakat; Xueying Zheng; Cynthia B Gilley; Mary MacDonald; Karl Okolotowicz; John R Cashman; Shubham Vyas; Jeremy M Beck; Christopher M Hadad; Jun Zhang
Journal:  Chem Res Toxicol       Date:  2009-10       Impact factor: 3.739

8.  A collaborative endeavor to design cholinesterase-based catalytic scavengers against toxic organophosphorus esters.

Authors:  Patrick Masson; Florian Nachon; Clarence A Broomfield; David E Lenz; Laurent Verdier; Lawrence M Schopfer; Oksana Lockridge
Journal:  Chem Biol Interact       Date:  2008-04-16       Impact factor: 5.192

9.  Design and expression of organophosphorus acid anhydride hydrolase activity in human butyrylcholinesterase.

Authors:  C B Millard; O Lockridge; C A Broomfield
Journal:  Biochemistry       Date:  1995-12-12       Impact factor: 3.162

10.  Analogues with fluorescent leaving groups for screening and selection of enzymes that efficiently hydrolyze organophosphorus nerve agents.

Authors:  Luis Briseño-Roa; Jim Hill; Stuart Notman; David Sellers; Andy P Smith; Christopher M Timperley; Janet Wetherell; Nichola H Williams; Gareth R Williams; Alan R Fersht; Andrew D Griffiths
Journal:  J Med Chem       Date:  2006-01-12       Impact factor: 7.446

View more
  4 in total

1.  His-tag truncated butyrylcholinesterase as a useful construct for in vitro characterization of wild-type and variant butyrylcholinesterases.

Authors:  Erik C Ralph; Longkuan Xiang; John R Cashman; Jun Zhang
Journal:  Protein Expr Purif       Date:  2011-07-23       Impact factor: 1.650

2.  The methionase chain reaction: an enzyme-based autocatalytic amplification system for the detection of thiols.

Authors:  Jeremy David Adams; Joachim Justad Røise; David Sam Lee; Niren Murthy
Journal:  Chem Commun (Camb)       Date:  2020-02-17       Impact factor: 6.222

3.  Immunodetection of serum albumin adducts as biomarkers for organophosphorus exposure.

Authors:  Sigeng Chen; Jun Zhang; Lucille Lumley; John R Cashman
Journal:  J Pharmacol Exp Ther       Date:  2012-11-28       Impact factor: 4.030

4.  Advances in toxicology and medical treatment of chemical warfare nerve agents.

Authors:  Mohammd Moshiri; Emadodin Darchini-Maragheh; Mahdi Balali-Mood
Journal:  Daru       Date:  2012-11-28       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.